Qurratul Ann Warsi

Qurratul Ann (Annie) Warsi, MD, MAS, serves as the Executive Medical Director of Clinical Development at Antiva Biosciences, Inc. With a robust background in clinical development, Warsi has held senior positions including Senior Medical Director at Priovant Therapeutics and Medical Director roles at Mirum Pharmaceuticals and Myovant Sciences, where responsibilities included leading clinical strategy and execution. Warsi began their career as a Medical Writer at Penumbra, Inc. Educated at the University of California, San Francisco, Warsi earned a Master’s Degree in Advanced Studies in Clinical Research, focusing on Epidemiology and Biostatistics, as well as completing Advanced Training in Clinical Research during 2015 to 2017.